SUPN market cap is ~$265M (OS ~31M shares) with 2 approved drugs now selling (the 1st since feb.13 and the 2nd since sept.13) and getting royalties from a 3rd now. they've enough cash through 2014, some p2 drugs in the pipeline and are expecting to be cashflow breakeven at the end of 2014. and there are about 28% shares of float short 11/29/2013 with insider holding 25.4M shares per 09/30/2013.